1,571
Views
20
CrossRef citations to date
0
Altmetric
Special Focus

Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs

, , &
Pages 224-231 | Received 12 May 2014, Accepted 25 Sep 2014, Published online: 17 Oct 2014
 

Abstract

Aims: The way people who inject drugs (PWID) feel about drug policy may be profoundly shaped by lived experience of stigma and the subjectivities made available in policy and practice. Using a community-based participatory research approach, this study investigated why PWID hold particular views, and considered the complexities of how lived experience and opinions about drug policy intersect within this affected community. Methods: Three qualitative focus groups were undertaken. Participants were presented with survey results arising from a previous study, and asked to interpret and explain the possible rationales underlying the opinions expressed by their peers. Findings: A duality of opinion was identified, borne from lived experience of stigmatisation, which sometimes led PWID to qualify levels of support. By exploring the rationales underlying opinions, a tension emerged between what PWID theoretically know to be effective interventions, and experiences of how policies are delivered. A sense of “within-group” stigma emerged, with sub-groups of users and drug types denoted as more “dangerous” than others. Conclusions: This study illustrates how theoretical knowledge and lived experience intersect to inform opinions about drug policy. Through in-depth discussions with the affected community, we are reminded that public opinion research is always an interpretative and sensitive pursuit.

Acknowledgements

The authors thank all the participants who contributed their time and expertise to this project.

Declaration of interest

This project was funded by the Centre for Research Excellence into Injecting Drug Use. The Drug Policy Modelling Programme is funded by the Colonial Foundation Trust, and is located at the National Drug and Alcohol Research Centre, a research centre funded by the Australian government. Alison Ritter is a recipient of a National Health and Medical Research Council Fellowship (APP1021988).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.